share_log

NeuroSense Shares Are Trading Higher After the Company Announced an Alzheimer's Drug Development Collaboration With Genetika+.

NeuroSense Shares Are Trading Higher After the Company Announced an Alzheimer's Drug Development Collaboration With Genetika+.

NeuroSense宣佈與Genetika+合作開發阿爾茨海默氏症藥物後，該公司股價走高。
Benzinga ·  04/22 20:33

NeuroSense Shares Are Trading Higher After the Company Announced an Alzheimer's Drug Development Collaboration With Genetika+.

NeuroSense宣佈與Genetika+合作開發阿爾茨海默氏症藥物後，該公司股價走高。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論